Latest Insider Transactions at Revolution Medicines, Inc. (RVMD)
This section provides a real-time view of insider transactions for Revolution Medicines, Inc. (RVMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Revolution Medicines, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Revolution Medicines, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2022
|
Alexis Borisy |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+8.65%
|
-
|
|
Jun 16
2022
|
Barbara Weber |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+32.86%
|
-
|
|
Jun 16
2022
|
Elizabeth M Anderson |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+32.86%
|
-
|
|
Jun 16
2022
|
Eric Thomas Schmidt |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+24.47%
|
-
|
|
Jun 16
2022
|
Flavia Borellini |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+29.49%
|
-
|
|
Jun 16
2022
|
Sushil Patel |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+50.0%
|
-
|
|
Jun 16
2022
|
Neil Exter Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+15.29%
|
-
|
|
Jun 08
2022
|
Neil Exter Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 08
2022
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
419,901
-7.6%
|
$8,398,020
$20.25 P/Share
|
|
Mar 28
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
725
+0.07%
|
$17,400
$24.71 P/Share
|
|
Mar 25
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
42,000
+2.13%
|
$1,008,000
$24.93 P/Share
|
|
Mar 24
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
49,119
+5.02%
|
$1,178,856
$24.26 P/Share
|
|
Mar 23
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
53,118
+2.95%
|
$1,221,714
$23.8 P/Share
|
|
Mar 22
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
130,127
+5.09%
|
$2,992,921
$23.01 P/Share
|
|
Mar 21
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
75,731
+4.92%
|
$1,514,620
$20.97 P/Share
|
|
Mar 18
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
82,200
+6.01%
|
$1,561,800
$19.83 P/Share
|
|
Mar 17
2022
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
159
-0.79%
|
$2,862
$18.62 P/Share
|
|
Mar 17
2022
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
1,023
-0.55%
|
$18,414
$18.61 P/Share
|
|
Mar 17
2022
|
Xiaolin Wang |
SELL
Open market or private sale
|
Direct |
240
-0.75%
|
$4,320
$18.61 P/Share
|
|
Mar 17
2022
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
321
-0.11%
|
$5,778
$18.62 P/Share
|
|
Mar 17
2022
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
321
-0.5%
|
$5,778
$18.61 P/Share
|
|
Mar 17
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
10,120
+1.85%
|
$182,160
$18.78 P/Share
|
|
Mar 11
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
3,110
+0.59%
|
$62,200
$20.93 P/Share
|
|
Mar 10
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
40,400
+3.62%
|
$808,000
$20.9 P/Share
|
|
Mar 09
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
39,600
+7.55%
|
$792,000
$20.07 P/Share
|
|
Mar 08
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
103,833
+7.7%
|
$1,972,827
$19.16 P/Share
|
|
Mar 07
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
103,005
+12.17%
|
$1,854,090
$18.63 P/Share
|
|
Mar 04
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
56,300
+19.12%
|
$957,100
$17.69 P/Share
|
|
Mar 03
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
65,637
+14.95%
|
$1,181,466
$18.78 P/Share
|
|
Mar 02
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
116,290
+50.0%
|
$2,093,220
$18.94 P/Share
|
|
Mar 01
2022
|
Xiaolin Wang |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+38.51%
|
-
|
|
Mar 01
2022
|
Jack Anders Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,600
+36.67%
|
-
|
|
Mar 01
2022
|
Margaret A Horn Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,800
+37.63%
|
-
|
|
Mar 01
2022
|
Stephen Michael Kelsey |
BUY
Grant, award, or other acquisition
|
Direct |
38,800
+11.78%
|
-
|
|
Mar 01
2022
|
Mark A Goldsmith |
BUY
Grant, award, or other acquisition
|
Direct |
104,000
+35.79%
|
-
|
|
Dec 17
2021
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
1,571
-1.87%
|
$37,704
$24.41 P/Share
|
|
Dec 17
2021
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
491
-1.89%
|
$11,784
$24.41 P/Share
|
|
Dec 17
2021
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
343
-0.14%
|
$8,232
$24.41 P/Share
|
|
Dec 17
2021
|
Xiaolin Wang |
SELL
Open market or private sale
|
Direct |
257
-2.11%
|
$6,168
$24.41 P/Share
|
|
Dec 17
2021
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
170
-1.98%
|
$4,080
$24.41 P/Share
|
|
Dec 06
2021
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
37,721
+30.94%
|
$0
$0.49 P/Share
|
|
Sep 17
2021
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
479
-1.81%
|
$14,370
$30.02 P/Share
|
|
Sep 17
2021
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
1,531
-3.19%
|
$45,930
$30.02 P/Share
|
|
Sep 17
2021
|
Xiaolin Wang |
SELL
Open market or private sale
|
Direct |
250
-2.01%
|
$7,500
$30.02 P/Share
|
|
Sep 17
2021
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
335
-0.13%
|
$10,050
$30.02 P/Share
|
|
Sep 17
2021
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
166
-1.99%
|
$4,980
$30.02 P/Share
|
|
Jun 22
2021
|
Alexis Borisy |
BUY
Grant, award, or other acquisition
|
Direct |
3,617
+6.78%
|
-
|
|
Jun 22
2021
|
Barbara Weber |
BUY
Grant, award, or other acquisition
|
Direct |
3,617
+40.0%
|
-
|
|
Jun 22
2021
|
Elizabeth M Anderson |
BUY
Grant, award, or other acquisition
|
Direct |
3,617
+40.0%
|
-
|
|
Jun 22
2021
|
Eric Thomas Schmidt |
BUY
Grant, award, or other acquisition
|
Direct |
3,617
+25.0%
|
-
|